The International Severe Acute Respiratory and emerging Infection Consortium’s (ISARIC) purpose is to prevent illness and deaths from infectious disease outbreaks. They are a global federation of clinical research networks, providing a proficient, coordinated, and agile research response to outbreak-prone infectious diseases. Within this network is ISARIC 4C, the Coronavirus Clinical Characterisation Consortium. They are a UK-wide consortium of doctors and scientists committed to answering urgent questions about COVID-19 quickly, openly, and for the benefit of all.
Dr Annemarie Docherty is part of this consortium. In her webinar – The ISARIC Study – she gives us some insights into some of the outputs which have been delivered due to the samples and data collected since the first cases were reported in the UK. And also how these outputs provide a foundation for other studies, such as clinical trials of new treatments, to help better understand the best way to use interventions.
(United Nations Covid19 Response)
